Transforming Gujarat: A Strategic Alliance for AI Leadership
In a significant stride towards Gujarat’s ambition to emerge as a premier hub for innovation and investment in the digital economy, a pivotal partnership agreement was recently inked between the State Department of Science and Technology and Intel Corporation.
Introduction to e-Aushadhi Portal by Kerala Government
The Kerala Ayurveda Siddha Unani Medicine State Licensing Authority has issued a circular mandating that all applications for services provided by the Drugs Control Ayurveda Department, such as drug manufacturing licenses and loan licenses, must now be submitted through the e-Aushadhi Portal.
Simplified Procedures for Tamil Nadu SDL 2024 Bondholders
Investors holding the 9.02% Tamil Nadu State Development Loan (SDL) 2024 are informed about the forthcoming repayment process, ensuring a seamless transaction without any interest accruing after August 13, 2024.
From Paper to Pixels: Puducherry Mandates Digital Factories Act Returns
In a bid to streamline administrative processes and reduce compliance burdens, the Government of Puducherry has issued an order mandating the submission of half-yearly returns under the Factories Act, 1948, through online channels only.
MoHFW Notifies New Draft Drug Rules (….Amendment),2024
The Ministry of Health and Family Welfare on July 10th issued the Draft Drug Rules (….Amendment),2024, to further amend the Drugs and Cosmetics Rules ,1945.
Key Amendments :
Rule 74: This rule will now include Schedule G drugs in clause (p), which deals with specific regulatory requirements.
Rule 74A: Clause (i) of this rule will also be amended to include Schedule G drugs, outlining additional guidelines for their manufacture and distribution.
Rule 74B: Amendment in clause (7) will specify regulatory measures concerning Schedule G drugs, ensuring stringent adherence to safety protocols.
Rule 78: Clause (q) will now encompass Schedule G drugs, strengthening oversight during the licensing and registration process.
Rule 78A: This amendment in clause (8) will further outline the responsibilities and requirements related to Schedule G drugs for manufacturers and distributors.
Govt. Of Haryana Issues Latest Stamp Rule Amendments
The Government of Haryana issued new rules to amend the Punjab Stamp Rules Of 1934, on 9th July 2024. The new rule shall be called the Punjab Stamp (Haryana Amendment) Rules, 2024.
26 Amendment: This change affects who can sell stamps and the limits on their value:For court fee stamps: No one can sell a single stamp worth more than Rs. 20,000.
For e-stamps: Similarly, no e-stamp can be sold for more than Rs. 20,000 in value. Stamp vendors are only allowed to sell e-stamps up to Rs. 100 in denomination.
The amendments include the following:
Rule 28: These amendments increase the maximum value of stamps that can be issued or sold:The previous limit of Rs. 10,000 has been raised to Rs. 20,000
Rule 33 Amendments: D
The previous limit of Rs. 10,000 has been raised to Rs. 20,000. This means that for certain types of stamps and legal documents, the value of stamps required has been doubled.
MCA Specified Companies (Furnishing of information about payment to micro and small enterprise suppliers) Amendment Order, 2024
MCA provides that those specified companies which are having payments pending to any micro or small enterprises for more than 45 days from the date of acceptance or the date of deemed acceptance of the goods or services under section 9 of the Micro, Small and Medium Enterprises Development Act, 2006 shall furnish the information in MSME Form-I.
MCA revises Form No. MGT-6 & BEN 2
MCA revises Form No. MGT-6 & BEN 2 with immediate effect.
UGC has prohibited sales of unhealthy foods in educational institutions
The Higher Education lnstitutions (HEls) are once again requested to implement the prohibition of sales of unhealthy foods in educational institutions and promote healthy food options in canteens to curb the ongoing epidemic of NCDs effectively by reducing the consumption of unhealthy ultra processed of HFSS foods.
Revised Master Directions on Fraud Risk Management in the Regulated Entities
These Master Directions have been prepared based on a comprehensive review of the earlier Master Directions, Circular and emerging issues. These Master Directions are principle-based and strengthen the role of the Board in overall governance and oversight of fraud risk management in the Regulated Entities (REs).
